CHOU2 PHARMA Opens INAD Files to Develop Portfolio of New Cannabinoid-based Companion Animal Drugs

NARBERTH, Pa., Nov. 15, 2024 /PRNewswire/ — Chou2 Pharma, LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has opened a portfolio of INAD files with CVM. The new drug indications Chou2 Pharma…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.